Peer-influenced content. Sources you trust. No registration required. This is HCN.
News Medical
A high-sensitivity KRAS-targeted blood test detects residual pancreatic cancer missed by standard assays, suggesting current monitoring approaches may underestimate recurrence risk despite treatment.
Gastroenterology July 13th 2026
American Journal of Clinical Pathology (AJCP)
Flow cytometric evaluation of MRD in AML demonstrates that blast phenotypes consistently show abnormalities but may evolve during treatment, emphasizing the importance of comprehensive antigen panel analysis for accurate detection.
Hematology February 20th 2025
Clinical Advances in Hematology & Oncology
ctDNA provides an intriguing, noninvasive means of evaluating solid organ malignancies—from early diagnosis to personalized treatment decisions to prognosis and estimating risk of recurrence.
Oncology, Medical July 25th 2022